Translating the Market Potential: Emisphere’s Inherent Opportunity
5 key therapeutic market opportunities with current sales totaling over $16 billion
Three are partnered and the other two are positioned for partnering
At 5% annual growth over 10 years: $26 billion
Oral and best in class should enable partners to expand respective markets and capture large market share
EMIS receives 10%+ in royalties from these sales without the requirement for any additional investment
EMIS’s strategy is to continue to identify pipeline filling opportunities
Disclosed Clinical Pipeline